6Burt M E,Brennan M F.Incidence of hypercalcemia and malignant neoplasm[J].Arch Surg,1980,115(6):704-707.
7Ohsawa M,Soda M,Mizunuma H.Drugs in development for the treatment of osteoporosis:incadronate[J].Nippon Rinsho,2002,60(Suppl 3):538-543.
8Mizunuma H,Soda M,Okano H,et al.Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome[J].Hum Reprod,1998,13(10):2816-2818.
9Oura S,Sakurai T,Yoshimura G,et al.Study on the safety of rapid infusion and the efficacy of incadronate against bone metastasis of breast cancer[J].Gan To Kagaku Ryoho,1999,26(11):1623-1628.
10Okazaki A,Sakai H,Matsuzawa T,et al.Intravenous single and repeated dose toxicity studies of cimadronate (YM175),a novel bisphosphonate,in rats[J].J Toxicol Sci,1995,20 (Suppl 1):15-26.
2F Fulfaro,A Casuccio,C Ticozzi,et al.The role of bisphosphonates in the treatment of painful metastatic bone disease:a review of phase Ⅲ trials[J].Pain,1998,(78):157-169.
3M Botteman,V Barghout,J Stephens,et al.Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases[J].European Society for Medical Oncology,2006,7(17):1072-1082.
